Literature DB >> 17763433

B cell infiltration in systemic sclerosis-associated interstitial lung disease.

Robert Lafyatis1, Carl O'Hara, Carol A Feghali-Bostwick, Eric Matteson.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17763433     DOI： 10.1002/art.22847

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  49 in total

Review 1.  [Clinical risk-adapted therapies in systemic sclerosis].

Authors:  G Riemekasten; D Dragun
Journal:  Z Rheumatol       Date:  2007-12       Impact factor: 1.372

Review 2.  The role of the acquired immune response in systemic sclerosis.

Authors:  Carlo Chizzolini; Francesco Boin
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

3.  Decreased CD22 expression and intracellular signaling aberrations in B cells of patients with systemic sclerosis.

Authors:  Konstantinos Melissaropoulos; Stamatis-Nick Liossis
Journal:  Rheumatol Int       Date:  2018-06-04       Impact factor: 2.631

Review 4.  B-lymphocyte lineage cells and the respiratory system.

Authors:  Atsushi Kato; Kathryn E Hulse; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

Review 5.  Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.

Authors:  Elizabeth R Volkmann; Donald P Tashkin
Journal:  Ann Am Thorac Soc       Date:  2016-11

Review 6.  B cells in systemic sclerosis: from pathophysiology to treatment.

Authors:  Konstantinos Melissaropoulos; Dimitrios Daoussis
Journal:  Clin Rheumatol       Date:  2021-03-21       Impact factor: 2.980

7.  Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab.

Authors:  Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2010-01-08       Impact factor: 2.631

8.  B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis.

Authors:  Robert Lafyatis; Eugene Kissin; Michael York; Giuseppina Farina; Kerry Viger; Marvin J Fritzler; Peter A Merkel; Robert W Simms
Journal:  Arthritis Rheum       Date:  2009-02

9.  The role of B cells in systemic sclerosis.

Authors:  Marina D Kraaij; Jacob M van Laar
Journal:  Biologics       Date:  2008-09

10.  Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study.

Authors:  Dimitrios Daoussis; Stamatis-Nick C Liossis; Athanassios C Tsamandas; Christina Kalogeropoulou; Alexandra Kazantzi; Chaido Sirinian; Maria Karampetsou; Georgios Yiannopoulos; Andrew P Andonopoulos
Journal:  Rheumatology (Oxford)       Date:  2009-05-15       Impact factor: 7.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.